Prethrombin-1

Prethrombin-1 is a novel hemostatic development candidate designed for the fast, safe, and effective treatment of severe bleeding.
It was developed to address the urgent clinical need for rapid haemorrhage control while maintaining a favourable safety profile in critical care settings.

Potential clinical applications include:

• Bleeding in patients with coagulation disorders
• Breakthrough bleeding events
• Reversal of anticoagulation in patients receiving direct oral anticoagulant (DOAC) therapy
• Severe bleeding associated with traumatic injuries

• These indications represent significant unmet medical needs and provide a strong basis for clinical and commercial partnering opportunities.